Moleculin Biotech MBRX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 2.29 | -3.54 | -7,874 | -13 | ||
| 2025Q4 | 3.31 | -48.44 | 30.58 | -7,533 | 16 | |
| 2025Q3 | 13.25 | 16.86 | -30.75 | -5,907 | -35 | |
| 2025Q2 | 7.55 | 74.87 | -11 | -5,720 | -8 | |
| 2025Q1 | 24.34 | 92.34 | -17.25 | -5,943 | -6 | |
| 2024Q4 | 42.5 | 288.95 | -21.89 | -6,643 | -2 | |
| 2024Q3 | 71 | 67.37 | -74.5 | -7,136 | -11 | |
| 2024Q2 | 88 | 143.2 | -42.25 | -6,185 | -4 | |
| 2024Q1 | 147.75 | 134.35 | -50.5 | -6,677 | -5 | |
| 2023Q4 | 321.9 | 86.85 | -128.25 | -8,919 | -10 | |
| 2023Q3 | 160.31 | 106.01 | -70.25 | -5,946 | -6 | |
| 2023Q2 | 217.05 | 107.3 | -75 | -6,412 | -6 | |
| 2023Q1 | 360 | 105.55 | -103.25 | -8,354 | -8 | |
| 2022Q4 | 397.5 | 104.11 | -88.01 | -7,048 | -7 | |
| 2022Q3 | 397.5 | 105.5 | -112.49 | -9,085 | -9 | |
| 2022Q2 | 543.75 | 109.68 | -90 | -7,433 | -7 | |
| 2022Q1 | 667.5 | 103.01 | -90 | -7,074 | -7 | |
| 2021Q4 | 697.5 | 184.25 | -33.75 | -5,205 | -3 | |
| 2021Q3 | 1125 | 140.57 | -56.25 | -6,157 | -4 | |
| 2021Q2 | 1376.25 | 130.02 | -56.25 | -5,518 | -4 |